(Q67560081)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405323%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

title

A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405323%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference

J W Eschbach

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405323%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

N R Haley

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405323%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

J C Egrie

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405323%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

J W Adamson

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405323%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

language of work or name

English

0 references

publication date

1 August 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405323%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405323%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405323%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405323%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

page(s)

407-416

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405323%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1992.302

15 September 2019

exact match

0 references

cites work

Anemia of end-stage renal disease (ESRD).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Role of the kidney in erythropoiesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Plasma erythropoietin in chronic uraemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

The anaemia of chronic renal insufficiency; the effect of serum from azotaemic patients on the maturation of normoblasts in suspension cultures

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Mechanism of the anemia of chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Identification of Spermine as an Inhibitor of Erythropoiesis in Patients with Chronic Renal Failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Physiologic studies in normal and uremic sheep: I. The experimental model

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Treatment of the anemia of predialysis patients with recombinant human erythropoietin: a randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Treatment of the anemia of progressive renal failure with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Ferrokinetics: a biologic model for plasma iron exchange in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

The bleeding time as a screening test for evaluation of platelet function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

URAEMIC BLEEDING: ROLE OF ANAEMIA AND BENEFICIAL EFFECT OF RED CELL TRANSFUSIONS

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Recombinant human erythropoietin shortens the uraemic bleeding time without causing intravascular haemostatic activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Radioimmunoassay of erythropoietin in chronic uraemia or anephric patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Do polyamines play a role in the pathogenesis of the anemia of end-stage renal disease?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Polyamines in the anemia of end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Exceptionally high serum erythropoietin activity in an anephric patient with severe anemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Hemodialysis and continuous ambulatory peritoneal dialysis effects on erythropoiesis in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Disorders of Red Blood Cell Production in Uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis: the role of erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Spermine and spermidine are non-specific inhibitors of in vitro hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Hematopoietic inhibitors in chronic renal failure: lack of in vitro specificity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

The anemia of end-stage renal disease: hematopoietic progenitor cell response

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Anaemia of chronic renal failure. Polyamines are not raised in uraemic serum

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Absence of Anemia in Maintenance Hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Serum concentrations of erythropoietin measured by radioimmunoassay in hematologic disorders and chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Organ distribution of erythropoietin messenger RNA in normal and uremic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Recombinant human erythropoietin for patients with AIDS treated with zidovudine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Erythropoietin treatment of anemia associated with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

The heterogeneity of circulating human serum erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.302

7 January 2021

Identifiers

DOI

10.1038/KI.1992.302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1405323%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

15 September 2019

0 references

1 reference